PE33896A1 - Composicion farmaceutica para el tratamiento del malestar gastrico - Google Patents

Composicion farmaceutica para el tratamiento del malestar gastrico

Info

Publication number
PE33896A1
PE33896A1 PE27413595A PE27413595A PE33896A1 PE 33896 A1 PE33896 A1 PE 33896A1 PE 27413595 A PE27413595 A PE 27413595A PE 27413595 A PE27413595 A PE 27413595A PE 33896 A1 PE33896 A1 PE 33896A1
Authority
PE
Peru
Prior art keywords
treatment
pharmaceutical composition
nizatidine
gastric discomfort
tablet
Prior art date
Application number
PE27413595A
Other languages
English (en)
Spanish (es)
Inventor
Dolores Dimaria
Michael Alan Brandley
Jeanette Louise Brandley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PE33896A1 publication Critical patent/PE33896A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE27413595A 1994-07-20 1995-07-18 Composicion farmaceutica para el tratamiento del malestar gastrico PE33896A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27763294A 1994-07-20 1994-07-20

Publications (1)

Publication Number Publication Date
PE33896A1 true PE33896A1 (es) 1996-09-02

Family

ID=23061722

Family Applications (1)

Application Number Title Priority Date Filing Date
PE27413595A PE33896A1 (es) 1994-07-20 1995-07-18 Composicion farmaceutica para el tratamiento del malestar gastrico

Country Status (4)

Country Link
AU (1) AU3132495A (fr)
CO (1) CO4410201A1 (fr)
PE (1) PE33896A1 (fr)
WO (1) WO1996002262A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019259791B2 (en) 2018-04-27 2024-03-28 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055661A1 (fr) * 1990-12-21 1992-06-22 Manley A. Paulos Traitement des maux d'estomac associes aux brulures d'estomac ou a une hyperacidite gastrique au moyen d'une formulationeffervescente bloquant h2
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
KR100238565B1 (ko) * 1991-04-04 2000-02-01 데이비드 엠 모이어 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
CO4410201A1 (es) 1997-01-09
WO1996002262A2 (fr) 1996-02-01
AU3132495A (en) 1996-02-16
WO1996002262A3 (fr) 1997-02-13

Similar Documents

Publication Publication Date Title
ES2195308T3 (es) Composicon farmaceutica de fenofibrato que presenta una biodisponibilidad elevada, y metodo para su preparacion.
PE20000954A1 (es) Composiciones farmaceuticas
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
ES2124303T3 (es) Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
UY24875A1 (es) Composiciones farmacéuticas conteniendo tetrahidrolipstatina
MX174336B (es) Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacion
TR200001761T2 (tr) Çoklu terapilerde aktif esasların tatbiki için bir çift kapsül.
AR042051A1 (es) Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer
ES2097787T3 (es) Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.
BR9506028A (pt) Forma farmacêutica oral de múltipla dosagem unitária em tablete processos para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem e para o tratamento das doenças inflamatórias gastrointestinais em mamiíferos e no homem e embalagem de ampola de pressão transversal
KR890004684A (ko) 신속 방출제 전달계와 완속 방출제 전달계로 된 제형(劑刑)
AR002266A1 (es) Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye
CL2008000489A1 (es) Metodo para ajustar el perfil de los niveles en sangre o la permeacion de un farmaco desde una composicion; y composicion para la administracion transdermica que comprende a dicho farmaco y un vehiculo farmaceuticamente aceptable.
NO20024919D0 (no) Hydrofil/lipofil polymer matriksdoseringsformulering
CO5611096A2 (es) Forma de dosificacion farmaceutica para administracion mucosal
KR830005854A (ko) 알카리성 진통제 캡슐의 제조방법
PE58998A1 (es) Terapia combinada para la osteoporosis
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
WO2006021160A8 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
BR9807992A (pt) Comprimidos para engolir os quais compreendem paracetamol
AR011106A1 (es) COMPOSICIoN FARMACÉUTICA PARA EL TRAMIENTO O PREVENCI.ON DE LA DIABETES MELLITUS TIPO 2,
CL2004000577A1 (es) Tableta bioadhesiva con depresiones concentricas, paralelas, rectas y/o curvas que comprende una sustancia auxiliar bioadhesiva y un agente lubricante donde la relacion entre ellos es de 1:1300 a 1:1.
AR036085A1 (es) Formas de dosificacion y procedimiento para su fabricacion
ES509179A0 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".

Legal Events

Date Code Title Description
FC Refusal